VE202 in Patients With Mild-to-Moderate Ulcerative Colitis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Ulcerative Colitis, Colitis, Ulcerative

In brief

A Phase 2 study to evaluate the safety, efficacy, and microbiota changes of VE202 in patients with mild to moderate ulcerative colitis (UC).

Key facts

Study ID
NCT05370885
Run by
Vedanta Biosciences, Inc.
People needed
114
Starts
2023-05-08
Expected to finish
2025-08-29
Last updated by the study team
2025-12-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.